DJIA 17,827.75 0.00 0.00%
NASDAQ 4,787.32 0.00 0.00%
S&P 500 2,072.83 0.00 0.00%
market minute promo

Gilead Sciences (NASDAQ: GILD)

100.30 0.00 (0.00%)

REAL-TIME: Last trade at

Extended Hours: $100.38 $0.08 (0.08%)
Quote as of (NASDAQ)

company name or ticker

Recent Quotes

GILD $100.30 0.00%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $101.25
Previous Close $100.30
Daily Range $99.83 - $101.55
52-Week Range $63.50 - $116.83
Market Cap $151.3B
P/E Ratio 17.93
Dividend (Yield) $0.00 (0.0%)
Volume 11,535,699
Average Daily Volume 16,540,245
Current FY EPS $7.93





Gilead Sciences (GILD) Description

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide. Website:

News & Commentary Rss Feed

Should Gilead Sciences, Inc. Pay a Dividend?

Shares of Gilead Sciences have skyrocketed over the past two years, propelling the company into the upper echelons of the healthcare sector in terms of market cap. With all of its new peer group offering a dividend, should Gilead follow suit?

Johnson & Johnson's Rezolsta Approved in the EU for HIV-1 - Analyst Blog

Mixed Readings For Biotech Short Interest

#PreMarket Primer: Wednesday, November 26: Big Retailers Gear Up For Black Friday

Dow Chemical, NXP Semi, Gilead Sciences Set for Gains, Lucia Capital CEO Says

For Gilead, Are Products More Important Than Price?

Why You Shouldn't Bet Against Gilead Sciences (GILD) Stock - Tale of the Tape

3 Stocks Underperforming Today In The Drugs Industry

3 Simple Reasons Doctors May Stick With Gilead Sciences Instead of AbbVie

Gilead Sciences hepatitis C drug Harvoni offers three important advantages over AbbVie's competing hepatitis C drug cocktail.

Despite Recent Hiccup, Gilead Is Still A Blue Chip Gem

See More GILD News...

GILD's Top Competitors

GILD $100.30 (0.00%)
Current stock: GILD
AMGN $164.72 (0.00%)
Current stock: AMGN
CELG $112.61 (0.00%)
Current stock: CELG
$0.00 (0.00%)
Current stock: